Endocrine control of cyclic adenosine 3',5'-monophosphate levels in several Morris hepatomas.
D000311:Adrenal Glands / Q000502:physiology*; D000315:Adrenalectomy; D000367:Age Factors; D000621:Aminoisobutyric Acids / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001692:Biological Transport; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism*; D005260:Female; D005934:Glucagon / Q000008:administration & dosage / Q000494:pharmacology*; D007279:Injections, Subcutaneous; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects; D008113:Liver Neoplasms / Q000378:metabolism*; D008297:Male; D009374:Neoplasms, Experimental / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains
D000621:Aminoisobutyric Acids; D005934:Glucagon; D000242:Cyclic AMP; D007545:Isoproterenol